PFIZER INC
New York, NY 3 13Fs · since 2025 Q3
- $239M
- 18 Positions
- 2026 Q1
- +1.3% QoQ
- Top 5 79.7%
Portfolio
top 5 79.7% · top 10 96.2%
- Oric Pharmaceuticals 24.1%
- ALLO - Allogene Therapeutics 20.9%
- ARVN - Arvinas 14.6%
- CELC - Celcuity 13.1%
- Zura Bio 7.0%
- Wave Life 5.0%
- Pyxis Oncology 3.9%
- CRBU - Caribou Biosciences 3.5%
- Spero Therapeutics 2.3%
- Biohaven 1.8%
- CRDF - Cardiff Oncology 1.6%
- Zentalis Pharmaceutic… 0.8%
- Other 1.4%
AUM over time
Latest book
| Oric Pharmaceuticals | 24.14% | Reduce −11.1% | $58M | 4,780,401 | $12.06 | $58M | −595,943 | +$14M |
| ALLO - Allogene Therapeutics | 20.85% | Hold | $50M | 22,032,040 | $2.26 | $50M | — | — |
| ARVN - Arvinas | 14.63% | Hold | $35M | 3,457,815 | $10.10 | $35M | — | — |
| CELC - Celcuity | 13.13% | Reduce −15.4% | $31M | 295,652 | $106.02 | $31M | −53,754 | −$4M |
| Zura Bio | 7.05% | Reduce −4.4% | $17M | 2,838,913 | $5.93 | $17M | −131,109 | +$1M |
| Wave Life | 5.00% | Hold | $12M | 1,875,000 | $6.36 | $12M | — | — |
| Pyxis Oncology | 3.86% | Hold | $9M | 7,032,770 | $1.31 | $9M | — | — |
| CRBU - Caribou Biosciences | 3.50% | Hold | $8M | 4,690,431 | $1.78 | $8M | — | — |
| Spero Therapeutics | 2.31% | Hold | $6M | 2,362,348 | $2.33 | $6M | — | — |
| Biohaven | 1.77% | Hold | $4M | 505,645 | $8.37 | $4M | — | — |
| CRDF - Cardiff Oncology | 1.57% | Hold | $4M | 2,411,575 | $1.55 | $4M | — | — |
| Zentalis Pharmaceutic… | 0.84% | Hold | $2M | 953,834 | $2.10 | $2M | — | — |
| Nextcure | 0.64% | Reduce −2.7% | $2M | 153,354 | $10.01 | $2M | −4,292 | −$702K |
| AGMB - Agomab Therapeutics | 0.34% | New | $814K | 75,000 | $10.85 | $814K | +75,000 | +$814K |
| Q32 Bio | 0.31% | Reduce −63.4% | $737K | 101,618 | $7.25 | $737K | −176,159 | −$185K |
| BOLT - Bolt Biotherapeutics | 0.06% | Hold | $137K | 31,305 | $4.38 | $137K | — | — |
| Ginkgo Bioworks | 0.01% | Hold | $17K | 2,928 | $5.93 | $17K | — | — |
| Senseonics | 0.01% | Hold | $14K | 2,171 | $6.56 | $14K | — | — |
| ANTX - An2 Therapeutics | 0.34% | Exit | $815K | 0 | $1.14 | $815K | −715,295 | −$815K |
filings history
3 periods · normalized AUM · click period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q1 | 18 | $239M | +1.3% | 13F-HR | 5/12/2026 | 000007800326000064 |
| 2025 Q4 | 18 | $236M | −46.0% | 13F-HR | 2/12/2026 | 000007800326000013 |
| 2025 Q3 | 21 | $437M | — | 13F-HR | 11/13/2025 | 000007800325000161 |
About
PFIZER INC
3 processed 13Fs · since 2025 Q3